These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7400715)

  • 1. Partial purification of low molecular weight non-suppressible insulin-like activity from human plasma: demonstration of the presence of multiple forms.
    Cockerill PN; Cornell HJ; Herington AC
    J Endocrinol; 1980 May; 85(2):266-77. PubMed ID: 7400715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (NSILA) in human serum.
    Cornell HJ; Herington AC
    Int J Biochem; 1983; 15(4):553-8. PubMed ID: 6852354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
    Cornell HJ; Bistrin M; Herington AC
    Int J Biochem; 1985; 17(9):1003-8. PubMed ID: 4065403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of a basic somatomedin, from human plasma Cohn fraction IV-1, with physicochemical and radioimmunoassay similarity to somatomedin-C and insulin-like growth factor.
    Bala RM; Bhaumick B
    Can J Biochem; 1979 Nov; 57(11):1289-98. PubMed ID: 575503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a specific inhibitor of nonsuppressible insulin-like activity in a partially purified human serum fraction.
    Herington AC; Kuffer AD
    Endocrinology; 1981 Nov; 109(5):1634-40. PubMed ID: 7297496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The occurrence of a distinct high molecular weight form of serum non-suppressible insulin-like activity.
    Franklin RC; Cameron DP; Burger HG; Herington AC
    Mol Cell Endocrinol; 1979 Nov; 16(2):81-9. PubMed ID: 41788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic conversion of insulin-like growth factors to an acidic form(s).
    Kuffer AD; Herington AC
    Biochem J; 1984 Oct; 223(1):97-103. PubMed ID: 6388567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.
    Cornell HJ; Enberg G; Herington AC
    Biochem J; 1987 Feb; 241(3):745-50. PubMed ID: 3593220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of different isolation procedures on the yields of insulin-like growth factors from human plasma.
    Cornell HJ
    Prep Biochem; 1982; 12(1):57-76. PubMed ID: 7048285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial purification and characterization of somatomedin from sheep serum.
    Hossner KL; Davis SL; Powell C; Sasser RG
    Endocrinology; 1985 Apr; 116(4):1351-6. PubMed ID: 3971919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2365-9. PubMed ID: 1065887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity.
    Herington AC; Kuffer AD
    Biochem J; 1984 Oct; 223(1):89-96. PubMed ID: 6388566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of insulin-like growth Factors I and II from human plasma.
    Cornell HJ; Boughdady NM; Herington AC
    Prep Biochem; 1984; 14(2):123-38. PubMed ID: 6384997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic peptide with insulin-like activity in human serum.
    Sasaki N; Okabe T; Imai Y; Matsuzaki F; Kosaka K; Wakai K; Tsushima T
    Endocrinol Jpn; 1981 Apr; 28(2):157-67. PubMed ID: 7030722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of different extraction procedures on two different molecular weight species of serum NSILA and on the carrier protein of small molecular weight NSILA (NSILA-S).
    Kaufmann U; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1979 Apr; 90(4):637-47. PubMed ID: 34963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The purification and partial characterization of an insulin-like protein from human serum.
    Poffenbarger PL
    J Clin Invest; 1975 Dec; 56(6):1455-63. PubMed ID: 1202080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved method for the purification of human insulin-like growth factors I and II.
    Petrides PE; Hintz RL; Bohlen P; Shively JE
    Endocrinology; 1986 May; 118(5):2034-8. PubMed ID: 3698905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial purification, characterization, and assay of a slightly acidic insulin-like peptide (ILAs) from human plasma.
    Posner BI; Guyda HJ; Corvol MT; Rappaport R; Harley C; Goldstein S
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1240-50. PubMed ID: 400741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.